References

Andermann A, Blancquaert I, Beauchamp S, Déry V (2008). Revisiting Wilson and Junger in the genomic age: a review of screening criteria over the past 40 years. Bulletin of the World Health Organization. 86: 241-320.

Bruni L, Diaz M, Castellsague M et al (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infec Dis 202:1789-9.

Castanon A, Brocklehurst P, Evans H et al. (2012)  Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study. BMJ 345:e5174 doi:10.1136.

Castanon A, Leung VMW, Landy R, Lim AWW, Sasieni P (2013). Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years. Br J Cancer 109;35-41.

Demay RM (1985). The Art & Science of Cytopathology (Exfoliative Cytopathology). American Society of Clinical Pathology (Chapter 3: Statistics).

Health and Social Care Information Centre (2014). Cervical screening programme, England.  Statistics for 2013-14.  Available at: www.cancerscreening.nhs.uk/

Khalid S, Dimtriou E, Conroy R et al. (2012) The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG 119:685-91.

Kyrgiou M, Mitra A, Arbyn M et al. (2014). Fertility and early  pregancy outcomes after treatment of cervical intraepithelial neoplasia: systemic review and meta-analysis. BMJ 349: doi:10.1136/bmj.g6192

Lalkhen AG, McCluskey A (2008). Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 8:221-3.

Walboomers JM, Jacobs MV, Manos MM et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwice. J Pathol 189:12-9.

Wilson LMG, Jungner G (1968). Principles and practice of screening for disease.  Geneva: WHO; 1968. Available from: http://apps.who.int/iris/bitstream/10665/37650/1/WHO_PHP_34.pdf?ua=1 (accessed 14.1.15)

X